PROBLEM TO BE SOLVED: To provide metabolic biomarkers for autism.SOLUTION: The present invention provides methods and biomarkers for diagnosing autism by identifying cellular metabolites which are distinctly produced in samples from autism patients in comparison with non-autistic controls. Described herein is a method for identifying specific profiles of metabolites existing or secreted in the brain tissue, cerebrospinal fluid, plasma or biofluid. The individual metabolites or a pattern of secreted metabolites provide metabolic signatures of autism, which can be used to provide a diagnosis of autism.
METABOLIC BIOMARKERS FOR AUTISM